Lifecore Biomedical LFCR Ratios (2010-2025)

NASDAQ LFCR
$4.09 -0.22 (-5.10%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Lifecore Biomedical Quarterly Ratios

Periods 60 quarters
Latest May 2025

Lifecore Biomedical reported a gross margin of 33.28% and a net margin of -24.72% for the quarter ended May 2025. These financial ratios cover 60 quarters of results from Aug 2010 through May 2025, standardized by Business Quant from the company’s SEC filings.

Ratios Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Mar2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025
Profitability
Gross Margin
23.35%45.28%39.31%32.46%24.83%44.76%33.04%37.09%25.20%25.97%32.21%24.98%11.12%33.02%33.31%45.59%21.81%34.04%28.01%33.28%
EBT Margin
-60.76%-41.69%-11.80%-44.47%-46.04%4.97%-21.38%-13.21%-28.25%-42.06%-42.43%-118.05%-51.06%47.02%42.02%-18.85%-65.80%-20.05%-42.04%-22.19%
EBIT Margin
-46.76%5.78%0.26%-14.77%-18.91%14.41%-27.36%-8.94%-13.80%-24.48%-24.61%-21.31%-35.13%-4.92%-2.51%5.67%-46.89%-6.02%-25.68%7.44%
EBITDA Margin
-46.76%5.78%0.26%-14.77%-18.91%14.41%-27.36%-8.94%-13.80%-24.48%-24.61%-21.31%-35.13%-4.92%-2.51%5.67%-46.89%-6.02%-25.68%7.44%
Operating Margin
-46.76%5.78%0.26%-14.77%-18.91%14.41%-27.36%-8.94%-13.80%-24.48%-24.61%-21.31%-35.13%-4.92%-2.51%5.67%-46.89%-6.02%-25.68%7.44%
Net Margin
-58.34%-52.23%-25.09%-37.25%-43.30%-150.27%-49.59%-198.32%-46.22%-58.57%-137.58%-126.13%-43.85%47.16%43.78%-18.70%-65.70%-26.73%-44.53%-24.72%
FCF Margin
54.68%-5.67%-42.55%-17.74%-31.72%-39.98%-66.04%-42.51%-18.81%-28.36%-70.94%-30.29%-54.58%-9.86%-21.80%15.84%-16.33%-26.35%-12.11%-1.40%
Efficiency
Inventory AverageInventory Avg.
47.61M30.66M31.92M32.69M35.40M38.29M37.24M35.38M36.08M37.29M40.23M41.44M41.27M41.57M40.56M39.82M40.81M40.43M36.91M33.44M
Assets AverageAssets Avg.
398.27M500.56M502.47M504.37M473.31M433.02M372.77M299.47M270.54M271.18M256.31M245.10M249.58M245.72M246.03M250.10M250.39M251.10M246.54M238.52M
Invested CapitalInvested Cap.
381.46M367.00M388.25M395.85M348.95M321.62M262.06M284.18M275.01M269.05M133.92M81.19M76.04M95.05M115.57M136.76M182.09M127.52M127.16M131.77M
Asset Utilization RatioAsset Util.
1.190.710.460.240.250.280.340.370.420.400.390.420.420.460.490.510.510.520.530.69
Leverage & Solvency
Interest Coverage RatioInterest Cover
-6.370.860.03-2.85-0.691.33-2.62-1.50-1.01-1.48-1.35-1.69-2.74-0.46-0.270.44-2.63-0.42-1.870.54
Debt Ratio
0.320.320.370.390.350.390.370.710.740.720.420.340.360.380.400.490.430.440.530.54
Times Interest Earned
-6.370.860.03-2.85-0.691.33-2.62-1.50-1.01-1.48-1.35-1.69-2.74-0.46-0.270.44-2.63-0.42-1.870.54
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
FCF Payout RatioFCF Cover
Dividend YieldDiv. Yield
Payout Ratio
Valuation
Price to EarningsP/E
-22.79-24.35-46.85-20.98-33.12-6.64-19.47-5.23-27.50-19.80-4.86-6.13-23.7616.0915.77-24.25-11.42-31.06-13.27-14.06
Price to SalesP/S
13.3012.7211.767.8214.349.989.6610.3612.7111.606.687.7310.427.596.904.537.508.305.913.48
Price to BookP/B
1.381.451.621.741.661.642.393.323.873.565.06-56.92-18.84160.9813.9415.182.4717.5093.52186.24
Enterprise Value
301.05M300.14M325.10M350.35M319.31M254.99M339.12M290.30M299.01M247.65M174.42M221.67M255.53M228.75M246.51M163.30M185.39M260.87M202.30M240.55M
EV to EBIT
-28.40218.440.00M-52.82-75.6169.10-35.19-115.52-91.33-46.27-26.71-33.39-29.66-154.25-275.4375.99-16.00-133.17-22.4145.16
EV to EBITDA
-28.40218.440.00M-52.82-75.6169.10-35.19-115.52-91.33-46.27-26.71-33.39-29.66-154.25-275.4375.99-16.00-133.17-22.4145.16
Market Capitalization
301.49M302.61M326.95M351.12M320.25M255.60M340.22M291.29M301.55M253.59M177.37M240.76M255.53M228.75M246.51M171.76M185.39M270.33M207.71M248.82M
Price to FCFP/FCF
24.32-224.32-27.63-44.06-45.22-24.98-14.62-24.38-67.58-40.89-9.42-25.52-19.09-76.94-31.6728.61-45.95-31.51-48.79-247.58
EV to FCF
24.28-222.49-27.48-43.96-45.09-24.92-14.57-24.30-67.01-39.94-9.27-23.49-19.09-76.94-31.6727.20-45.95-30.40-47.52-239.35
EV to CFO
17.48244.01-45.9868.90231.55-53.01-19.59-156.75-271.58-105.25-14.88-98.00-30.68177.60-173.8518.74-302.43-42.49168.7236.74
Return Ratios
Return on Sales [ROS]ROS
-46.76%5.78%0.26%-14.77%-18.91%14.41%-27.36%-8.94%-13.80%-24.48%-24.61%-21.31%-35.13%-4.92%-2.51%5.67%-46.89%-6.02%-25.68%7.44%
Return on Capital Employed [ROCE]ROCE
-13.12%-7.56%-2.55%-3.92%-2.55%-2.28%-5.95%-10.32%-12.78%-27.50%-8.07%-10.59%-12.67%-11.32%-8.43%-4.19%-5.63%-5.69%-9.48%-8.28%
Return on Invested Capital [ROIC]ROIC
-5.67%-4.70%-1.80%-2.98%-1.93%-1.14%-4.18%-3.66%-3.57%-8.70%-8.90%-20.36%-34.71%-27.39%-17.13%-6.87%-7.32%-8.03%-16.02%-13.33%
Return on Assets [ROA]ROA
-12.80%-11.32%-10.37%-9.79%-9.68%-16.59%-22.09%-40.52%-45.34%-35.77%-45.27%-40.62%-39.81%-29.43%-8.21%4.80%2.61%-5.68%-18.11%-22.43%